News
Fredun Pharmaceuticals standalone net profit rises 127.87% in the September 2025 quarter
10-Nov-2025 | 08:20
Sales rise 34.33% to Rs 143.59 crore
Net profit of Fredun Pharmaceuticals rose 127.87% to Rs 9.73 crore in the quarter ended September 2025 as against Rs 4.27 crore during the previous quarter ended September 2024. Sales rose 34.33% to Rs 143.59 crore in the quarter ended September 2025 as against Rs 106.89 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 143.59 | 106.89 | 34 |
| OPM % | 15.55 | 13.04 | - |
| PBDT | 14.60 | 8.63 | 69 |
| PBT | 13.00 | 7.57 | 72 |
| NP | 9.73 | 4.27 | 128 |
Powered by Capital Market - Live News